Acute low back pain (mechanical)MANAGEMENT

MUSCULOSKELETAL AND RHEUMATOLOGIC PRESENTATIONS · 12 SECTIONS

⚲

516 items

☷ Legend

01Approach to the Critical Patient/attcp46

Triage and immediate stabilization

›Immediate risk screen

›If hemodynamic instability, resuscitation bay

›If hypotension or syncope, ruptured AAA consideration

›If fever and toxicity, spinal infection consideration

›If severe or progressive neurologic deficit, emergent spine pathway

›If saddle anesthesia or urinary retention, cauda equina pathway

›If recent major trauma, spinal fracture pathway

›If anticoagulation with trauma, spinal epidural hematoma consideration

›If severe constant pain unrelenting at rest, serious pathology consideration

›If night pain with systemic symptoms, malignancy or infection consideration

Red flags and cannot miss diagnoses

›Red flag clusters

›Cauda equina syndrome red flags

›Urinary retention or overflow incontinence

›New fecal incontinence

›Saddle anesthesia

›Bilateral sciatica

›Progressive motor weakness in legs

›Spinal infection red flags

›Fever or rigors

›Recent bacteremia or skin infection

›Immunosuppression

›Injection drug use

›Recent spinal procedure

›Malignancy red flags

›Known cancer history

›Unexplained weight loss

›Persistent pain despite conservative care

›Age associated risk increase

›Fracture red flags

›Major trauma

›Minor trauma with osteoporosis risk

›Chronic systemic glucocorticoids

›Vascular and retroperitoneal red flags

›Abdominal pain or pulsatile mass

›Syncope or shock

›Anticoagulation with flank or back pain

Initial management targets

›Early shared plan

›Benign course framing for uncomplicated mechanical pain

›Most episodes improve within days to weeks

›Imaging rarely changes management without red flags

›Functional target

›Walking and light activity as tolerated

›Avoid prolonged bed rest

›Analgesia pathway selection

›Nonopioid first-line

›Opioid reserved only if severe refractory pain

02History/hx60

Symptom characterization and functional impact

›Mechanical low back pain features

›Pain location

›Midline or paraspinal lumbar pain

›Radiation to buttock or thigh without dermatomal pattern

›Time course

›Acute duration less than 4 weeks

›Trigger event such as lifting or twisting

›Provokers and relievers

›Worse with movement or prolonged sitting

›Improved with position change or gentle activity

›Functional limitation

›Walking tolerance

›Work and school limitations

›Sleep disruption

›Prior episodes

›Recurrence pattern

›Prior response to NSAIDs or physical therapy

Neurologic symptom screen

›Radicular and cord symptoms

›Leg pain below knee

›Dermatomal distribution

›Worse with cough or Valsalva

›Numbness or tingling

›Dermatomal sensory change

›Saddle anesthesia

›Weakness

›Foot drop symptoms

›Difficulty toe or heel walking

›Bowel and bladder symptoms

›Urinary retention

›New incontinence

Risk factors and exposures

›Serious pathology risk review

›Trauma

›High-energy mechanism

›Minor trauma with osteoporosis risk

›Infection risk

›Fever history

›Injection drug use

›Immunosuppressive therapy

›Recent spinal injection or surgery

›Malignancy risk

›Cancer history

›Constitutional symptoms

›Inflammatory back pain pattern

›Morning stiffness over 30 minutes

›Improvement with exercise

›Alternating buttock pain

›Pregnancy possibility

›Last menstrual period timing

›Ectopic pregnancy risk symptoms if abdominal pain

Medical coding alignment

›Coding considerations

›ICD-10 low back pain unspecified M54.50

›Use when nonspecific mechanical back pain without clear injury code

›ICD-10 strain of muscle and tendon of lower back S39.012A

›Use when clear acute lifting or twisting strain mechanism

›ICD-10 lumbar radiculopathy M54.16

›Use when dermatomal pain with neurologic findings

›SNOMED CT terminology alignment

›Low back pain concept

›Lumbar strain concept

›Lumbar radiculopathy concept

03Physical Exam/exam45

General and lumbar exam

›Focused exam set

›Vitals and fever check

›Temperature elevation as infection signal

›Hypotension or tachycardia as hemorrhage signal

›Inspection

›Posture and antalgic stance

›Skin lesions suggesting zoster

›Palpation

›Paraspinal tenderness

›Midline bony tenderness

›Range of motion

›Pain with flexion or extension

›Reproduction with movement

Neurologic exam

›Lower extremity neuro screen

›Motor testing

›Hip flexion L2 to L3

›Knee extension L3 to L4

›Ankle dorsiflexion L4 to L5

›Great toe extension L5

›Plantarflexion S1

›Sensory testing

›Dermatomal light touch

›Saddle region sensation if concern

›Reflexes

›Patellar L3 to L4

›Achilles S1

›Gait

›Heel walk weakness

›Toe walk weakness

Provocative maneuvers and special tests

›Maneuvers

›Straight leg raise

›Reproduction of radicular pain below knee

›Contralateral straight leg raise specificity support

›Seated slump test

›Radicular symptom reproduction

›Hip exam for mimics

›Pain with internal rotation suggesting hip pathology

›Abdominal and vascular screen when indicated

›Pulsatile mass assessment

›Costovertebral angle tenderness for renal colic mimic

Pitfalls

›Common misses

›Normal early strength in evolving cauda equina

›Bladder symptoms as early clue

›Fever absence in spinal epidural abscess

›Risk factor based escalation

04Differential Diagnosis/ddx33

High-risk causes to exclude

›Emergent causes

›Cauda equina syndrome

›ICD-10 G83.4

›Saddle anesthesia and urinary retention pattern

›Spinal epidural abscess

›Back pain with neurologic deficit or infection risk

›Vertebral osteomyelitis or discitis

›Persistent pain with fever or bacteremia risk

›Spinal epidural hematoma

›Anticoagulation or procedure history

›Vertebral compression fracture

›Osteoporosis or steroid exposure

›Abdominal aortic aneurysm rupture or leak

›Older age or vascular disease with back pain and shock

Common benign and mimics

›Nonemergent causes

›Mechanical low back pain and lumbar strain

›Paraspinal tenderness with movement pain

›Lumbar radiculopathy from disc herniation

›Dermatomal pain with positive straight leg raise

›Spinal stenosis

›Neurogenic claudication

›Facet arthropathy

›Pain with extension and rotation

›Sacroiliac joint pain

›Buttock pain with provocation tests

›Hip pathology

›Osteoarthritis or labral pathology mimic

›Renal colic or pyelonephritis

›Flank pain and urinary symptoms

›Herpes zoster

›Dermatomal pain preceding rash

›Inflammatory spondyloarthropathy

›Morning stiffness and improvement with exercise

05Laboratory Tests/lt28

No red flags

›Routine testing avoidance

›No labs for uncomplicated acute mechanical low back pain

›Low diagnostic yield without red flags

›Management unchanged by routine labs

Infection or inflammatory concern

›Inflammatory and infection evaluation

›Complete blood count for fever or systemic symptoms

›Leukocytosis limited sensitivity for spinal infection

›Normal count does not exclude epidural abscess

›C-reactive protein for suspected spinal infection

›Elevation supports inflammatory process

›Trend utility for response when diagnosis confirmed

›Erythrocyte sedimentation rate for suspected vertebral osteomyelitis

›Elevation supports further imaging when risk factors present

›Normal value lowers likelihood but not exclusion

›Blood cultures for suspected bacteremia source

›Before antibiotics if unstable not delaying resuscitation

Genitourinary and pregnancy related evaluation

›Contextual tests

›Urinalysis for dysuria or flank pain

›Hematuria supports renal colic mimic

›Pyuria supports UTI or pyelonephritis mimic

›Pregnancy test for reproductive potential and uncertain status

›Imaging pathway modification if positive

›Ectopic pregnancy mimic consideration if abdominal pain

Medication safety baseline

›NSAID and acetaminophen safety checks when indicated

›Serum creatinine for known CKD or dehydration risk

›NSAID nephrotoxicity risk stratification

›Liver risk review for high dose acetaminophen plan

›Chronic alcohol use and hepatic disease caution

06Diagnostic Tests/dt44

Scoring Systems

›Functional and psychosocial tools

›STarT Back Screening Tool for chronicity risk

›Higher psychosocial risk tier supports early multidisciplinary approach

›Not an emergent disease exclusion tool

›Oswestry Disability Index for baseline disability

›Serial tracking for recovery trajectory

›Higher disability supports expedited follow-up

›Roland-Morris Disability Questionnaire for function tracking

›Useful in outpatient and rehab settings

›Change over time guides return to activity

MRI

›MRI lumbar spine indications

›Emergent MRI triggers

›Suspected cauda equina syndrome

›Suspected spinal epidural abscess

›Suspected spinal epidural hematoma

›Urgent MRI triggers

›Progressive or severe neurologic deficit

›Suspected malignancy with neurologic findings

›MRI timing for refractory symptoms

›Persistent symptoms after conservative care with intervention candidacy

›ACR guidance supports imaging after trial of management when no red flags

›MRI limitations

›Incidental degenerative findings common

›Clinical correlation required to avoid overdiagnosis

›CT and radiography roles

›CT lumbar spine use cases

›Suspected fracture with equivocal radiographs

›MRI contraindication when serious pathology evaluation required

›Radiography lumbar spine use cases

›Low velocity trauma with osteoporosis risk

›Chronic steroid exposure with acute pain

›CT limitations

›Limited soft tissue discrimination for epidural abscess compared with MRI

›Radiation exposure consideration

Ultrasound (or US)

›Ultrasound applications

›Aorta ultrasound for suspected AAA

›Rapid bedside evaluation in unstable patient

›Immediate vascular pathway if aneurysm identified

›Renal ultrasound for hydronephrosis when renal colic mimic

›Supports alternate diagnosis pathway

›Does not exclude small stones without hydronephrosis

›Soft tissue ultrasound for paraspinal abscess concern

›Limited utility for deep spinal pathology

›Adjunct for superficial collections only

07Disposition/dispo28

Discharge criteria for uncomplicated mechanical pain

›Safe discharge features

›No red flags on history and exam

›No bowel or bladder dysfunction

›No progressive neurologic deficit

›Pain controlled enough for ambulation

›Able to walk and perform basic activities

›Acceptable plan for sleep and function

›Clear follow-up plan

›Primary care or physiotherapy access

›Reassessment timing if not improving

Admission and urgent consultation

›Higher level care triggers

›Suspected cauda equina syndrome

›Emergent spine surgery consultation

›Emergent MRI pathway

›Suspected spinal infection

›Blood cultures and antibiotics pathway when indicated

›MRI and inpatient management

›Suspected fracture with instability

›Immobilization and orthopedic or spine consultation

›Uncontrolled pain with functional inability

›Short stay observation consideration

›Multimodal analgesia optimization

Return and follow-up intervals

›Reassessment thresholds

›Lack of meaningful improvement by 1 to 2 weeks

›Consider structured rehab escalation

›Re-evaluate for missed red flags

›Persistent symptoms beyond 4 to 6 weeks

›Imaging consideration if intervention candidate per guideline pathways

08Treatment/t107

Nonpharmacologic first-line

›Core measures

›Education and reassurance

›Favorable natural history for uncomplicated acute low back pain

›Avoidance of routine imaging without red flags

›Activity and mobility

›Continue usual activities as tolerated

›Avoid prolonged bed rest

›Heat therapy

›Superficial heat wrap 15 to 20 minutes sessions

›Skin burn avoidance counseling

›Early movement program

›Walking program

›Gentle stretching within pain limits

›Physical therapy referral when needed

›Persistent functional limitation

›Recurrent episodes with poor self-management success

Nonopioid analgesics

›NSAIDs

›Ibuprofen oral dosing

›Initiate 400 mg to 600 mg every 6 to 8 hours as needed

›Maximum 2400 mg per day for most patients

›Gastroprotection consideration in GI risk

›Naproxen oral dosing

›Initiate 250 mg to 500 mg twice daily as needed

›Maximum 1000 mg per day

›Longer half-life counseling

›Diclofenac oral dosing

›Initiate 50 mg three times daily as needed

›Maximum 150 mg per day

›Cardiovascular risk awareness

›NSAID contraindications and cautions

›CKD or dehydration risk

›Avoid or use lowest dose shortest course

›Serum creatinine review when indicated

›History of GI ulcer or GI bleeding

›Proton pump inhibitor co-therapy consideration

›Avoid if high risk without protection

›Heart failure or significant cardiovascular disease

›Avoid high dose prolonged courses

›Naproxen relative risk profile consideration

›Pregnancy third trimester

›Avoid due to fetal and ductal risk

›Obstetric guidance alignment

›Acetaminophen

›Oral dosing

›Initiate 650 mg every 6 hours as needed

›Alternate option 1000 mg every 8 hours as needed

›Maximum 3000 mg per day preferred outpatient ceiling

›Hepatic cautions

›Chronic liver disease

›Lower maximum daily dose

›Avoid combination products overuse

›Heavy alcohol use

›Lower maximum daily dose

›Counsel on overdose risk

›Topical agents

›Topical NSAID options

›Diclofenac gel to localized tender area

›Lower systemic exposure than oral

›Skin irritation monitoring

›Topical lidocaine

›Lidocaine patch 4 percent or 5 percent off-label for focal pain

›12 hours on then 12 hours off typical schedule

›Skin reaction monitoring

Muscle relaxants and adjuncts

›Skeletal muscle relaxants short course

›Cyclobenzaprine oral dosing

›Initiate 5 mg at bedtime

›Titrate to 5 mg three times daily if needed

›Maximum 10 mg three times daily

›Methocarbamol oral dosing

›Initiate 500 mg to 750 mg every 6 hours as needed

›Sedation counseling

›Avoid driving if impaired

›Tizanidine oral dosing

›Initiate 2 mg every 8 hours as needed

›Titrate in 2 mg increments

›Maximum 24 mg per day

›Adverse effects and cautions

›Sedation and falls risk

›Avoid in high fall risk patients

›Night dosing preference when possible

›Anticholinergic burden with cyclobenzaprine

›Avoid in older adults when possible

›Urinary retention risk

Opioids and restricted use

›Opioid avoidance as routine

›ACEP Level C guidance for acute low back pain discharge

›Nonopioid analgesics and nonpharmacologic therapies adequacy check before opioid prescription

›Opioids reserved for severe pain or pain refractory to other analgesics

›Lowest practical dose and limited duration

›CDC 2022 opioid guidance alignment for adults

›Lowest effective dose

›No longer than expected duration of severe pain

›Pediatric and adolescent caution

›Avoid initiating opioids for routine mechanical low back pain

›Follow local pediatric pain policies when unavoidable

Therapies to avoid in uncomplicated mechanical pain

›Low value or harmful options

›Routine imaging without red flags

›Increased incidental findings and downstream interventions

›No outcome benefit in uncomplicated acute pain

›Prolonged bed rest

›Delayed recovery association

›Deconditioning risk

›Routine systemic corticosteroids

›Limited benefit for nonspecific low back pain

›Adverse effect risk

›Benzodiazepines for back pain

›Sedation and dependence risk

›No clear functional benefit in uncomplicated cases

09Special Populations/sp42

Pregnancy

›Pregnancy considerations

›Alternative diagnoses and risk shifts

›UTI and pyelonephritis mimic

›Round ligament and pelvic girdle pain mimics

›Imaging modifications

›MRI preferred when serious spinal pathology suspected

›Avoid ionizing radiation when possible

›Medication safety

›Acetaminophen preferred first-line

›Lowest effective dose

›Maximum daily dose adherence

›NSAID avoidance in third trimester

›Ductus arteriosus risk

›Oligohydramnios risk

Geriatric

›Older adult considerations

›Higher fracture risk

›Low energy trauma relevance

›Osteoporosis and steroid exposure relevance

›Higher malignancy and infection risk baseline

›Lower threshold for targeted labs and imaging with red flags

›Atypical presentations more common

›Medication risk tailoring

›NSAID renal and GI risk increase

›Shortest course and gastroprotection consideration

›Avoid in advanced CKD

›Muscle relaxant fall risk

›Avoid routine use when possible

›If used, lowest dose bedtime strategy

Pediatrics

›Pediatric and adolescent considerations

›Higher relative concern for nonmechanical causes when persistent

›Spondylolysis in athletes

›Infection and inflammatory conditions

›Red flag emphasis

›Night pain

›Fever

›Weight loss

›Medication dosing principles

›Weight-based dosing policy adherence

›Avoid aspirin in children

›Sports and activity guidance

›Relative rest from provoking activity

›Gradual return with core strengthening program

10Background/b30

Epidemiology

›Burden and frequency

›Low back pain as common reason for seeking care

›High prevalence in primary care and emergency care settings

›Significant disability contribution worldwide

›Natural history

›Many acute episodes improve within weeks

›Recurrence within 1 year common

Pathophysiology

›Mechanical pain mechanisms

›Paraspinal muscle strain

›Microtears and local inflammation

›Spasm and protective guarding cycle

›Facet joint irritation

›Extension and rotation provoked pain pattern

›Localized referral to buttock common

›Disc related pain without radiculopathy

›Annular fissure irritation possible

›Imaging abnormalities common in asymptomatic individuals

Therapeutic Considerations

›Rationale for conservative care

›Imaging avoidance rationale

›No improved outcomes without red flags

›Incidental findings drive unnecessary interventions

›Activity continuation rationale

›Maintains conditioning and function

›Reduces fear avoidance behavior

›Analgesic strategy rationale

›NSAIDs modest short-term benefit in acute low back pain

›Muscle relaxants may improve short-term symptoms with sedation tradeoff

›Opioid minimization rationale

›Limited evidence of superiority for acute low back pain

›Misuse and long-term use risk

11Patient Discharge Instructions/pdi27

copy discharge instructions

›Discharge instructions

›Expected course

›Improvement typically within days to weeks

›Mild pain fluctuations with activity during recovery

›Activity guidance

›Keep moving with short frequent walks

›Avoid bed rest

›Avoid heavy lifting until improving

›Home care

›Heat pack 15 to 20 minutes up to several times daily

›Gentle stretching within pain limits

›Medications

›NSAID as directed if safe for kidneys and stomach

›Acetaminophen as directed without exceeding daily maximum

›Avoid alcohol and sedatives with muscle relaxants

›Follow-up

›Primary care or physiotherapy within 1 to 2 weeks if not improving

›Earlier follow-up if pain prevents normal walking or sleep

›Return to ED immediately

›New or worsening leg weakness

›New numbness in groin or saddle region

›New urine retention or new incontinence

›New fecal incontinence

›Fever or chills

›Unexplained weight loss

›Severe pain after trauma

›Fainting or severe abdominal pain with back pain

12References/r26

Clinical guidelines and key sources

›Core guidance sources

›American College of Physicians clinical practice guideline for noninvasive treatments for acute and subacute low back pain

›Initial nonpharmacologic options

›NSAIDs and skeletal muscle relaxants as medication options

›NICE guideline NG59 low back pain and sciatica in over 16

›Assessment framework

›Imaging and treatment recommendations

›ACR Appropriateness Criteria low back pain update

›No imaging for uncomplicated acute low back pain without red flags

›Imaging pathways for red flags and refractory symptoms

›Choosing Wisely Canada recommendation for low back imaging

›Avoid imaging without red flags

›Patient facing education alignment

›ACEP clinical policy on opioids 2012

›Level C recommendations for acute low back pain discharge opioid prescribing

›Community risk framing for opioid exposure

›CDC 2022 Clinical Practice Guideline for prescribing opioids for pain

›Lowest effective dose

›Short duration for acute pain when used

Additional evidence sources

›Supporting summaries and reviews

›VA and DoD guideline summary for low back pain

›Imaging not recommended without red flags

›Early imaging associated harms summary

›Canadian primary care and quality standard resources

›Imaging avoidance quality statement for acute low back pain

›Self-management and education quality statement

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed June 16, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.